Coronary sinus narrowing for the treatment of refractory angina A multi-center prospective open-label clinical study (The REDUCER-I study).

CONCLUSIONS: Interim results from the ongoing REDUCER-I study confirm the high safety profile of this therapy in patients suffering from refractory angina. The results also demonstrate sustained improvement in angina severity and in quality of life out to 2 years. PMID: 33319762 [PubMed - as supplied by publisher]
Source: EuroIntervention - Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research